Interní Med. 2010; 12(7-8): 376-381

Intracranial tumors: diagnosis and treatment

MUDr.Pavel Fadrus, Ph.D.1, MUDr.Radek Lakomý2, MUDr.Petra Hübnerová3, RNDr.Ondřej Slabý, Ph.D.4, MUDr.Miloš Keřkovský5, MUDr.Tomáš Svoboda1, MUDr.Václav Vybíhal1, MUDr.Eduard Neuman, Ph.D.1, MUDr.Soňa Kryštofová1, MUDr.Marek Sova1, prof.MUDr.Martin Smrčka, Ph.D., MBA1
1 Neurochirurgická klinika, LF MU a FN Brno
2 Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno
3 Klinika radiační onkologie, Masarykův onkologický ústav, Brno
4 Oddělení onkologické a experimentální patologie, Masarykův onkologický ústav, Brno
5 Radiologická klinika, LF MU a FN Brno

Primary malignant brain tumors account for only 2 % of all adult cancers but they cause a disproportionately high cancer-related disability and

death. Primary brain tumors according the WHO classification are classified based on their cellular origin and histological appearance. In this

review, we describe the standard treatment modalities for malignant and benign brain tumors, which include surgery, radiation therapy and

chemotherapy, as well as the status of novel therapies that have been developed to target various aspects of glioma cell biology. Common

presenting symptoms include headache, seizures, and altered mental status. Magnetic resonance imaging is the preferred initial imaging

study and the stereotactic biopsy is often required to confirm the diagnosis. Treatment depends on the histological diagnosis. Surgical

resection of the tumor is the mainstay of therapy. Postoperative radiation and chemotherapy have improved survival in patients with highgrade

brain tumors. Recent developments in targeted chemotherapy provide novel treatment options for patients with tumor recurrence.

Benign tumors and metastases are usually curable with surgical resection or radiation therapy including stereotactic radiation.

Keywords: brain tumors, surgery, stereotactic biopsy, immunochemistry, radiation therapy, chemotherapy

Published: August 12, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fadrus P, Lakomý R, Hübnerová P, Slabý O, Keřkovský M, Svoboda T, et al.. Intracranial tumors: diagnosis and treatment. Interní Med. 2010;12(7-8):376-381.
Download citation

References

  1. Kala M. Maligní nádory mozku dospělého věku. Praha: Galén, 1. vydání, 1998.
  2. Kozler P, et al. Intrakraniální nádory. Praha: Galén, 1. vydání, 2007.
  3. Náhlovský J, et al. Neurochirurgie. Praha: Galén, 1. vydání, 2006.
  4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System, Fourth Edition, 2007, 312 p.
  5. Šlampa P, Petera J, et al. Radiační onkologie. Praha: Galén, 1. vydání, 2007.
  6. Šlampa P, Soumarová R, Kocáková I, et al. Konkomitantní chemoradioterapie solidních nádorů. Praha: Galén, 1. vydání, 2005.
  7. Brichtová E. Onemocnění dětského neurokrania. Praha: Triton, 2009.
  8. Mohapl M, Kramář F, Beneš V. Hydrocefalus jako následek subarachnoidálního krvácení z aneuryzmatu - review. In: Česká a slovenská neurologie a neurochirurgie, 2004, 67/100, 5: 309-314.
  9. Pavelka Z, Brichtová E, Křen L, et al. Radioterapií indukovaný glioblastom u dítěte léčeného pro meduloblastom mozečku. Klinická onkologie 2008; 21(1): 31-34. Go to PubMed...
  10. Lipina R, Paleček T. Chirurgické řešení hydrocefalu v dětském věku. Pediatrie pro praxi 2004, 3: 133-136.
  11. Kanta M, Ehler E, Ryšk P, et al. Neurofibrom n. ischiadikus v oblasti foramen infrapiriforme. Česká a Slovenská neurologie a neurochirurgie, 2003; 66(99) 2: 126-129.
  12. Česák T, Náhlovský J, Hosszú T, et al. Longitudinální sledování růstu pooperačních reziduí funkčních adenomů hypofýzy. Česká a Slovenská neurologie a neurochirurgie 2009, 72 (105) 2: 115-124.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.